Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents
- 1 October 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (12), 959-963
- https://doi.org/10.1016/0002-9149(90)90933-r
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- When is QT prolongation antiarrhythmic and when is it proarrhythmic?The American Journal of Cardiology, 1989
- Influence of thyroid hormone levels on the electrical and mechanical properties of rabbit papillary muscleJournal of Molecular and Cellular Cardiology, 1985
- Long QT: Good, bad or indifferent?Journal of the American College of Cardiology, 1984
- Amiodarone and thyroid function: Clinical implications during antiarrhythmic therapyAmerican Heart Journal, 1983
- Amiodarone: Historical development and pharmacologic profileAmerican Heart Journal, 1983
- Long QT Interval and Ventricular Tachycardia of “Torsade de Pointe” Type in HypothyroidismActa Medica Scandinavica, 1983
- Action of Thyroid Hormone on the Transmembrane Potentials from Sinoatrial Node Cells and Atrial Muscle Cells in Isolated Atria of RabbitsCardiology, 1973
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970
- The effect of altered thyroid state on atrial intracellular potentialsThe Journal of Physiology, 1970